Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in RDY — Dr Reddys Laboratories Ltd

CIK 861177 NEW YORK, NY
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$853,924
+$528,976 QoQ
Shares Held
58,932
+151.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 238 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $852,377,607 across 33 Drug Manufacturers - Specialty & Generic names. RDY ranks #26 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,924,988 $282,049,632
2 TEVA
Teva Pharmaceutical Industries Ltd
 3,832,465 $129,843,910
3 UTHR
UNITED THERAPEUTICS Corp
 218,164 $118,207,795
4 NBIX
Neurocrine Biosciences Inc
 504,233 $84,983,427
5 VTRS
Viatris Inc
 4,293,757 $68,184,856
6 LNTH
Lantheus Holdings, Inc.
 482,743 $53,555,505
7 ELAN
Elanco Animal Health Inc
 1,510,327 $37,169,144
8 HIMS
Hims & Hers Health, Inc.
 425,977 $14,768,619

All Filings in RDY

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $853,924 58,932
2026-03-31 $324,948 23,462
2025-12-31 $39,648 2,824
2025-09-30 $611,680 43,754
2025-06-30 $721,770 48,022
2025-03-31 $679,179 51,492
2024-12-31 $260,708 16,511
2024-09-30 $655,383 8,249
2024-06-30 $1,261,554 16,558
2024-03-31 $2,230,719 30,412
2023-12-31 $552,952 7,947
2023-09-30 $531,415 7,947
2023-06-30 $501,535 7,947
2023-03-31 $452,422 7,947
2022-12-31 $411,257 7,947
2022-09-30 $415,945 7,947
2022-06-30 $440,184 7,947
2022-03-31 $442,886 7,947
2021-12-31 $519,813 7,947
2021-09-30 $517,667 7,947
2021-06-30 $584,183 7,947